Industries — Allergy & Immunology
5 marketing mistakes allergy & immunology owners make
The five mistakes below cost allergy practice owners more money than any competitor does, and the first one is treating a measurement problem as a demand problem.
8 min read · Reviewed by both partners
None of these are exotic. They are the five that show up again and again when we read the numbers of a allergy practice that has been spending without moving.
They are listed in order of what they cost, not in order of how obvious they are. The expensive ones are rarely the obvious ones.
Allergy demand is one of the few in healthcare you can see coming on a calendar: patient volume tracks pollen seasons and respiratory-illness cycles that vary by region — the CDC and NIH publish the seasonal patterns — so an allergy practice’s marketing has a timing dimension a dermatologist’s simply does not.
Step by step
Buying attention before fixing the model
The instinct when growth stalls is more traffic. If patient volume tracks pollen and respiratory seasons, so campaign timing decides whether spend meets demand or misses it then added traffic amplifies a leak and the invoice arrives either way. Diagnose first; it is the cheapest step in the sequence.
Not knowing which source produced the revenue
Most allergy practice operators can state last quarter’s spend and not last quarter’s source mix. Without that, every budget decision after it is a guess wearing a decimal point.
Ignoring the vertical’s own rulebook
Spend that lands mid-season meets patients already suffering; the same spend in the off-season buys attention nobody is ready to use. Generic playbooks discover this after the money is spent.
Underfunding the thing that already works
Almost every allergy practice has one channel quietly outperforming the rest — often season-planned local search and content (built backward from your region’s allergy calendar). It is usually the one nobody has bothered to systematize, because it never asked for budget.
Killing programs at month four
Compounding channels look like failures right up until they do not. Programs get cancelled one quarter before payback more often than they get cancelled for being genuinely broken.
Common mistakes
Confusing activity with progress
A busy quarter of posting, posting, and posting produces a report full of numbers and a bank balance that has not moved. Ask what each activity was supposed to change.
Hiring for execution before strategy
A freelancer executing an undiagnosed plan produces well-made wrong work. For a allergy practice the sequencing matters more than the staffing.
Frequently Asked Questions
5 marketing mistakes allergy & immunology owners make?
None of these are exotic. They are the five that show up again and again when we read the numbers of a allergy practice that has been spending without moving.
Where does this fit in the Growth Scaling Method, and what should a business owner do next?
It sits under Allergy & Immunology in the Growth Scaling Method. The next step for an owner is the $1,500 Assessment, which reads your own numbers against everything described above.
What does working with Growth-Scaling cost?
Four thousand five hundred dollars for the Foundation, split evenly across three deliverables. Recurring work is quoted afterward and never starts below five thousand a month.
Do partners stay involved after the sale?
They are the only people involved. There is no handoff, because there is nobody to hand it to.
References
- www.data.gov — primary source
- www.samhsa.gov — primary source
- www.bls.gov — primary source
Find out which of these is costing you
Two hours and your real numbers name the constraint. The rest of the list stops mattering once you know.
Growth-Scaling is a marketing and business-scaling firm. It is not a licensed practitioner in any client vertical and does not provide medical, legal, financial, or contracting services; all industry content on this site is marketing and growth guidance for owners in those fields. Figures describing past engagements refer to specific businesses under specific conditions and are not a prediction of any future result. No outcome is promised.
Written by Steven Lockhart, reviewed by David Mitroff, Ph.D. Figures and regulatory details reflect the cited public sources; requirements vary by state and situation. Growth-Scaling is a marketing and business-scaling firm, not a licensed practitioner in any client vertical.